Professor Arnold W. Klein MD
Dr. Arnold William Klein, an internationally renowned dermatologist, is a world authority on minimally invasive aesthetics. He was born on February 27, 1945 in Mt. Clemens, Michigan and was raised in Michigan and Miami, Florida. He graduated cum laude with a BA degree in Biology from the University of Pennsylvania in 1967, and was graduated cum laude and Phi Beta Kappa from the University of Pennsylvania, School of Medicine, in 1971. Dr. Klein completed his post-graduate education as a medical intern at Cedars-Sinai Medical Center in Los Angeles, and went on to complete medical residencies in dermatology at the Hospital of the University of Pennsylvania and the University of California at Los Angeles, where he was the Chief Resident in Dermatology in 1975. Currently, Dr. Arnold Klein maintains an active private practice in Beverly Hills, CA, where he has been for more than 30 years. He is a Professor of Medicine and Dermatology at the David Geffen School of Medicine at UCLA, and has been honored with the establishment of the Arnold W. Klein Chair in Dermatology at UCLA, where he is a member of the academic and clinical staff. He is also an attending physician at the Cedars-Sinai Medical Center in Los Angeles.
Dr. Klein is a prolific writer and author; he has published nearly 150 scientific manuscripts in such prestigious peer-reviewed journals as the New England Journal of Medicine, Science Magazine and JAMA. He has written four medical textbooks, including his most recent, “Tissue Augmentation in Clinical Practice”, second Ed. Additionally, he has written numerous textbook chapters on Cosmetic Dermatology, Soft Tissue Augmentation, Aesthetic Surgery and botulinum toxins. In addition, he serves on the Editorial Board and as Expert Reviewer of numerous national and international medical publications, among them, the Journal of Plastic and Reconstructive Surgery, Journal of the American Academy of Dermatology, Dermatologic Surgery, Archives of Dermatology, Aesthetic Surgery, Aesthetic Buyers Guide, British Journal of Dermatology and the Journal of Cutaneous Aging and Cosmetic Dermatology, to name but a few.
Dr. Klein also serves as an advisor, consultant and principal investigator to Allergan, Anika Therapeutics, Elan Pharmaceuticals, Ethicon, Genzyme, Johnson & Johnson, Medicis Aesthetics, Ortho-Neutrogena, Skin-Medica and Q-Med.
In the early days of the AIDS crisis, Dr. Klein was the first physician to diagnose a case of Kaposi’s sarcoma in Southern California. This was the beginning of what has become a 25-year commitment to treating and finding a cure for AIDS. In 1984, in the living room of his Los Angeles home, Dr. Klein, along with David Geffen, Dr. Mathilde Krim and others founded the American Foundation for AIDS Research (amfAR), which he continues to serve as Founding Member and Director. Additionally, Dr. Klein is the founder of the Rose-Tarlow-Arnold W. Klein Breast Cancer Foundation at UCLA, which provides breast cancer treatment for individuals who are unable to afford such treatment.
Most recently, in honor of his dear friend Dame Elizabeth Taylor, Dr. Klein established the endowment for the Elizabeth Taylor Center for AIDS Research, Treatment and Education at UCLA, a facility with an international reputation in HIV/AIDS care. Dr. Klein serves as a Trustee to numerous Boards of Directors, including the Jennifer Jones-Simon Foundation, the UCLA Center for the Health Sciences and The Hereditary Disease Foundation, which discovered the first gene for Huntington’s chorea, and where along with his longtime friend Frank Ghery, works to raise funds and awareness for inherited diseases.
